ValiRx (VAL.L) Stock Price
£0.45 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
2 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on ValiRx, AI stock picks, stock alerts and much more.
VAL.L AI Stock Analysis
AI stock analysis for VAL.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like ValiRx (VAL.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
ValiRx (VAL.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of ValiRx (VAL.L), currently trading at £0.45, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About VAL.L
-
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.
-
Symbol
VAL.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
1.7M
Similar Stocks
 |
Codexis 0I0X.L |
$2.41 3% |
4 |
 |
Oxford Nanopore Technologies plc ONT.L |
£120 1% |
5 |
 |
Sareum Holdings SAR.L |
£14.25 1.1% |
3 |
 |
Viridian Therapeutics 0K1R.L |
$14.49 2.1% |
6 |
 |
Avacta Group Plc AVCT.L |
£32.5 5.1% |
3 |
News
VAL.L Alternative Data
Web Traffic
ValiRx receives an estimated 1385 monthly visitors to valirx.com.
-
Web Traffic
1385
-
Change from Previous Month
5.4%
-
3 Month Change
44.3%
-
YoY Change
44.3%
Job Postings
ValiRx currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
ValiRx has 473 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.9% over the last month.
-
Twitter Followers
473
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
1.7%
LinkedIn Followers
1,242 are following ValiRx on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
1242
-
Daily Change
1.6%
-
1 Month Change
1.6%
-
3 Month Change
8%
LinkedIn Employees
According to LinkedIn, ValiRx has 11 employees, down by -8.3% over the last month.
-
LinkedIn Employees
11
-
Daily Change
8.3%
-
1 Month Change
8.3%
-
3 Month Change
8.3%
News Mentions
ValiRx was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
ValiRx has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
VAL.L Financials
VAL.L Key Metrics
-
Total Revenue
£0
-
Net Income
-£970.9K
-
Earnings per Share
-£0.0074
-
Free cash flow
-£912K
-
EBITDA
-£917.6K
-
EBITDA Ratio
0
-
Total Assets
£3.7M
VAL.L 2-year Revenue & Income
VAL.L 2-year Free Cash Flow
VAL.L Technicals
VAL.L SMA
VAL.L RSI
FAQ
What's the current price of ValiRx (VAL.L) Stock?
The price of an ValiRx (VAL.L) share is £0.45.
What's the market cap of ValiRx?
The current market cap of ValiRx is 1.7M.
Should I buy or sell VAL.L?
ValiRx shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, ValiRx is better viewed as a hold or accumulate position while waiting for further developments.
Is ValiRx a good investment?
The current analysis of ValiRx's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in ValiRx's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy ValiRx (VAL.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for ValiRx stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to ValiRx (VAL.L) that investors often compare it to?
ValiRx (VAL.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for ValiRx's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast ValiRx's stock price to be around £0.448 in 2026. Starting from the current price of £0.45, this represents a 0.4% change in price, indicating a neutral outlook for the stock.
How to buy ValiRx (VAL.L) Stock?
ValiRx stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy ValiRx shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.